{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T10:44:35Z","timestamp":1793357075705,"version":"4.5.0"},"reference-count":242,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL136389"],"award-info":[{"award-number":["R01HL136389"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL147108"],"award-info":[{"award-number":["R01HL147108"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL089598"],"award-info":[{"award-number":["R01HL089598"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL160992"],"award-info":[{"award-number":["R01HL160992"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL164838"],"award-info":[{"award-number":["R01HL164838"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL163277"],"award-info":[{"award-number":["R01HL163277"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL153350"],"award-info":[{"award-number":["R01HL153350"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["936111"],"award-info":[{"award-number":["936111"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.yjmcc.2025.06.002","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T11:46:27Z","timestamp":1749469587000},"page":"37-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Mechanisms underlying atrial fibrillation in chronic kidney disease"],"prefix":"10.1016","volume":"205","author":[{"given":"Jose Alberto","family":"Navarro-Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xander H.T.","family":"Wehrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2022","key":"10.1016\/j.yjmcc.2025.06.002_bb0005","first-page":"7","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2011","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0010","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0015","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10741-010-9223-1","article-title":"Epidemiology and outcome of the cardio-renal syndrome","volume":"16","author":"Cruz","year":"2011","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0030","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0035","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehp507","article-title":"Acute dialysis quality initiative consensus, cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative","volume":"31","author":"Ronco","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.kint.2017.11.019","article-title":"Primary outcomes of the monitoring in dialysis study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle","volume":"93","author":"Roy-Chaudhury","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0045","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2215\/CJN.09350915","article-title":"Committees, arrhythmia and sudden death in Hemodialysis patients: protocol and baseline characteristics of the monitoring in dialysis study","volume":"11","author":"Charytan","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2215\/CJN.09420818","article-title":"Rates of cardiac rhythm abnormalities in patients with CKD and diabetes","volume":"14","author":"Akoum","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0055","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ahj.2010.03.027","article-title":"Chronic renal insufficiency cohort study, chronic kidney disease and prevalent atrial fibrillation: the chronic renal insufficiency cohort (CRIC)","volume":"159","author":"Soliman","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/cvr\/cvv275","article-title":"The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis","volume":"109","author":"Heijman","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCRESAHA.120.316363","article-title":"Molecular basis of atrial fibrillation pathophysiology and therapy: a translational perspective","volume":"127","author":"Nattel","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2215\/CJN.03170509","article-title":"Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease","volume":"5","author":"Ananthapanyasut","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ki.2011.416","article-title":"The prevalence of and factors associated with chronic atrial fibrillation in Medicare\/Medicaid-eligible dialysis patients","volume":"81","author":"Wetmore","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ahj.2009.06.031","article-title":"Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study","volume":"158","author":"Watanabe","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1053\/j.ajkd.2023.07.023","article-title":"Albuminuria, and risk of incident atrial fibrillation: a systematic review and meta-analysis","volume":"83","author":"Ha","year":"2024","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0095","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1681\/ASN.2018050514","article-title":"Cardiovascular events after new-onset atrial fibrillation in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study","volume":"29","author":"Bansal","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0100","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.ajkd.2017.08.016","article-title":"Incident atrial fibrillation and the risk of congestive heart failure, myocardial infarction, end-stage kidney disease, and mortality among patients with a decreased estimated GFR","volume":"71","author":"Massicotte-Azarniouch","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0110","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jacc.2019.08.1031","article-title":"Anticoagulation in concomitant chronic kidney disease and atrial fibrillation: JACC review topic of the week","volume":"74","author":"Kumar","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0115","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1097\/HJH.0b013e32833a7dfe","article-title":"Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients","volume":"28","author":"Horio","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155581","article-title":"Chronic kidney disease and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies","volume":"11","author":"Shang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1081\/JDI-100001285","article-title":"Symptomatic atrial arrhythmias in hemodialysis patients","volume":"23","author":"Ansari","year":"2001","journal-title":"Ren. Fail."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2006.04.026","article-title":"The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation","volume":"115","author":"Korantzopoulos","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0135","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","article-title":"Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"39","author":"Turakhia","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0140","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for geographic and racial differences in stroke (REGARDS) study","volume":"4","author":"Baber","year":"2011","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0145","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/ndt\/gfw084","article-title":"Sex hormones in women with kidney disease","volume":"31","author":"Ahmed","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0150","article-title":"Testosterone deficiency and chronic kidney disease","volume":"37","author":"Zitzmann","year":"2024","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2024.108145","article-title":"Chronic kidney disease and menopausal health: An EMAS clinical guide","volume":"192","author":"Cevik","year":"2025","journal-title":"Maturitas"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneph.2012.279","article-title":"Cardiorenal syndrome: pathophysiology and potential targets for clinical management","volume":"9","author":"Hatamizadeh","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0165","doi-asserted-by":"crossref","DOI":"10.2337\/dc21-0431","article-title":"Identification and predictors for cardiovascular disease risk equivalents among adults with diabetes mellitus","author":"Zhao","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0170","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-020-01128-y","article-title":"Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes","volume":"19","author":"Heo","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0175","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1111\/dom.15773","article-title":"The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease","volume":"26","author":"Escobar Vasco","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0180","article-title":"The bidirectional link between diabetes and kidney disease: mechanisms and management","volume":"15","author":"Kumar","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12933-021-01347-x","article-title":"Diabetes induces remodeling of the left atrial appendage independently of atrial fibrillation in a rodent model of type-2 diabetes","volume":"20","author":"Yosefy","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0190","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jc.2005-1904","article-title":"High glucose alters cardiomyocyte contacts and inhibits myofibrillar formation","volume":"91","author":"Dyntar","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213816","article-title":"High glucose-induced Cardiomyocyte damage involves interplay between endothelin ET-1\/ET(A)\/ET(B) receptor and mTOR pathway","volume":"23","author":"Pandey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0200","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1046\/j.1523-1755.1998.00868.x","article-title":"High glucose concentration causes a rise in [Ca2+]i of cardiac myocytes","volume":"53","author":"Smogorzewski","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0205","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41581-019-0158-z","article-title":"The role of inflammasomes in kidney disease","volume":"15","author":"Komada","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41440-024-01937-8","article-title":"Elucidating the complex interplay between chronic kidney disease and hypertension","author":"Nagata","year":"2024","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0215","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/jhh.2011.105","article-title":"Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications","volume":"26","author":"Lau","year":"2012","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0220","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/HYPERTENSIONAHA.122.19459","article-title":"Atrial fibrillation detection and management in hypertension","volume":"80","author":"Gawa\u0142ko","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0225","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0735-1097(00)00611-2","article-title":"Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation","volume":"35","author":"Goette","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0230","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1093\/eurheartj\/ehi478","article-title":"Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction","volume":"26","author":"Milliez","year":"2005","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0235","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/01.CIR.101.23.2678","article-title":"Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans","volume":"101","author":"Goette","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0240","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0002-9440(10)63363-9","article-title":"Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death","volume":"165","author":"Xiao","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0245","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/eurheartj\/ehl135","article-title":"Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation","volume":"27","author":"Yin","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.758157","article-title":"Interleukin-6-mediated-ca(2+) handling abnormalities contributes to atrial fibrillation in sterile pericarditis rats","volume":"12","author":"Liao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0255","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.113.003313","article-title":"Oxidized Ca(2+)\/calmodulin-dependent protein kinase II triggers atrial fibrillation","volume":"128","author":"Purohit","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jacc.2015.05.020","article-title":"Contractile Function during angiotensin-II activation: increased Nox2 activity modulates cardiac calcium handling via Phospholamban phosphorylation","volume":"66","author":"Zhang","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0265","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/HYPERTENSIONAHA.120.15016","article-title":"Platelets promote Ang II (angiotensin II)-induced atrial fibrillation by releasing TGF-beta1 (transforming growth factor-beta1) and interacting with fibroblasts","volume":"76","author":"Liu","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0270","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1248\/bpb.b18-00363","article-title":"IL-1\u03b2 plays an important role in pressure overload-induced atrial fibrillation in mice","volume":"42","author":"Matsushita","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0275","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41586-020-2890-8","article-title":"Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia","volume":"587","author":"Moreira","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0280","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ki.2008.169","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"74","author":"Rouached","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0285","first-page":"9481475","article-title":"Correlation between soluble alpha-klotho and renal Function in patients with chronic kidney disease: a review and meta-analysis","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semnephrol.2018.02.004","article-title":"Updates on the mechanisms and the care of cardiovascular calcification in chronic kidney disease","volume":"38","author":"Henaut","year":"2018","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0295","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.18632\/aging.102046","article-title":"The interplay between mineral metabolism, vascular calcification and inflammation in chronic kidney disease (CKD): challenging old concepts with new facts","volume":"11","author":"Viegas","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0300","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamacardio.2016.1445","article-title":"Association of fibroblast growth factor 23 with atrial fibrillation in chronic kidney disease, from the Chronic Renal Insufficiency Cohort Study","volume":"1","author":"Mehta","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0305","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1744-9987.12030","article-title":"Committee of Renal Data Registry of the Japanese Society for Dialysis, serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients","volume":"17","author":"Taniguchi","year":"2013","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0310","article-title":"Relationship between cardiovascular calcium and atrial fibrillation","volume":"11","author":"Lee","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0315","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.amjcard.2012.11.045","article-title":"Relation of serum phosphorus levels to the incidence of atrial fibrillation (from the atherosclerosis risk in communities [ARIC] study)","volume":"111","author":"Lopez","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0320","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12864-024-10197-2","article-title":"Serum electrolyte concentrations and risk of atrial fibrillation: an observational and mendelian randomization study","volume":"25","author":"Wu","year":"2024","journal-title":"BMC Genomics"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0325","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13964","article-title":"High-phosphate diet causes atrial remodeling and increases atrial fibrillation vulnerability via STAT3\/NF-kappaB signaling and oxidative stress","volume":"238","author":"Hsu","year":"2023","journal-title":"Acta Physiol (Oxford)"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0330","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1161\/CIRCULATIONAHA.111.067306","article-title":"Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation","volume":"125","author":"Voigt","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000541109","article-title":"Vitamin D status and treatment in ESKD: links to improved CKD-MBD laboratory parameters in a real-world setting","author":"Holden","year":"2024","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0340","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/bonekey.2013.232","article-title":"Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD)","volume":"3","author":"Nigwekar","year":"2014","journal-title":"Bonekey Rep."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinsp.2024.100437","article-title":"Association of serum 25-hydroxyvitamin D with cardiovascular and all-cause mortality in patients with chronic kidney disease: NHANES 2007\u20132018 results","volume":"79","author":"Li","year":"2024","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0350","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12937-019-0485-8","article-title":"The relationship between vitamin D and risk of atrial fibrillation: a dose-response analysis of observational studies","volume":"18","author":"Liu","year":"2019","journal-title":"Nutr. J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0355","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ahj.2023.05.024","article-title":"The effect of vitamin D(3) supplementation on atrial fibrillation in generally healthy men and women: the Finnish vitamin D trial","volume":"264","author":"Virtanen","year":"2023","journal-title":"Am. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0360","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40620-015-0236-7","article-title":"Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients","volume":"29","author":"Fusaro","year":"2016","journal-title":"J. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0365","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/HYPERTENSIONAHA.108.119602","article-title":"Expression of the vitamin d receptor is increased in the hypertrophic heart","volume":"52","author":"Chen","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0370","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jsbmb.2006.12.081","article-title":"Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice","volume":"103","author":"Rahman","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0375","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/ndt\/gfn549","article-title":"Calcitriol ameliorates capillary deficit and fibrosis of the heart in subtotally nephrectomized rats","volume":"24","author":"Koleganova","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0380","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jsbmb.2010.03.026","article-title":"Myocardial effects of VDR activators in renal failure","volume":"121","author":"Mizobuchi","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0385","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.toxlet.2021.10.016","article-title":"Vitamin D3 protects against nitrogen mustard-induced apoptosis of the bronchial epithelial cells via activating the VDR\/Nrf2\/Sirt3 pathway","volume":"354","author":"Yu","year":"2022","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0390","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0395","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ahj.2014.04.017","article-title":"Parathyroid hormone concentration and risk of cardiovascular diseases: the atherosclerosis risk in communities (ARIC) study","volume":"168","author":"Folsom","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0400","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2023.05.016","article-title":"Comparative effectiveness of alternative treatment approaches to secondary hyperparathyroidism in patients receiving maintenance hemodialysis: an observational trial emulation","volume":"83","author":"Platt","year":"2024","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0405","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.jacc.2011.01.041","article-title":"Elevation of parathyroid hormone levels in atrial fibrillation","volume":"57","author":"Rienstra","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0410","first-page":"159","article-title":"Association between serum parathyroid hormone levels and the prevalence of atrial fibrillation: the Dong-gu study, Korean","volume":"48","author":"Lee","year":"2018","journal-title":"Circ. J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0415","first-page":"H1998","article-title":"Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes","volume":"264","author":"Smogorzewski","year":"1993","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0420","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(03)00434-3","article-title":"FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death","volume":"113","author":"Wehrens","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0425","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/cvr\/cvp027","article-title":"Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way","volume":"82","author":"Tastan","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.775029","article-title":"Fibroblast growth Factor-23-klotho axis in cardiorenal syndrome: mediators and potential therapeutic targets","volume":"12","author":"Navarro-Garcia","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0435","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1152\/ajpendo.00596.2012","article-title":"FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy","volume":"304","author":"Touchberry","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0440","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0445","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/s41598-017-02068-6","article-title":"FGF23\/FGFR4-mediated left ventricular hypertrophy is reversible","volume":"7","author":"Grabner","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0450","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.113.005499","article-title":"Fibroblast growth factor-23 and incident atrial fibrillation: the multi-ethnic study of atherosclerosis (MESA) and the cardiovascular health study (CHS)","volume":"130","author":"Mathew","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0455","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/ndt\/gfy392","article-title":"Fibroblast growth factor-23 promotes rhythm alterations and contractile dysfunction in adult ventricular cardiomyocytes","volume":"34","author":"Navarro-Garcia","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0460","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.kint.2018.02.017","article-title":"The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk","volume":"94","author":"Pastor-Arroyo","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100688","article-title":"Prognostic value and link to atrial fibrillation of soluble klotho and FGF23 in hemodialysis patients","volume":"9","author":"Nowak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0470","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cyto.2018.08.005","article-title":"Lower soluble klotho and higher fibroblast growth factor 23 serum levels are associated with episodes of atrial fibrillation","volume":"111","author":"Mizia-Stec","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0475","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071574","article-title":"Klotho modulates pro-fibrotic activities in human atrial fibroblasts through inhibition of phospholipase C signaling and suppression of store-operated calcium entry","volume":"10","author":"Hung","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0480","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0485","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1046\/j.1523-1755.2002.00600.x","article-title":"The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia","volume":"62","author":"Himmelfarb","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0490","doi-asserted-by":"crossref","first-page":"7520231","DOI":"10.1155\/2016\/7520231","article-title":"Oxidative stress biomarkers and left ventricular hypertrophy in children with chronic kidney disease","volume":"2016","author":"Drozdz","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0495","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000441091","article-title":"Plasma xanthine oxidase activity is predictive of cardiovascular disease in patients with chronic kidney disease, independently of uric acid levels","volume":"131","author":"Gondouin","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0500","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.jrn.2010.05.002","article-title":"Indoxyl sulfate is a nephro-vascular toxin","volume":"20","author":"Niwa","year":"2010","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0505","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00467-013-2626-1","article-title":"Carotid intima media thickness, oxidative stress, and inflammation in children with chronic kidney disease","volume":"29","author":"Garcia-Bello","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0510","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2014.02.004","article-title":"CaMKII oxidative activation and the pathogenesis of cardiac disease","volume":"73","author":"Luczak","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0515","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2008.02.048","article-title":"A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation","volume":"133","author":"Erickson","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0520","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/CIRCRESAHA.110.221911","article-title":"Reactive oxygen species-activated ca\/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and ca overload","volume":"108","author":"Wagner","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0525","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yjmcc.2024.09.011","article-title":"Oxidative stress and atrial fibrillation","volume":"196","author":"Pfenniger","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0530","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000368940","article-title":"Update on inflammation in chronic kidney disease","volume":"39","author":"Akchurin","year":"2015","journal-title":"Blood Purif."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0535","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0540","article-title":"Cytokines: from clinical significance to quantification","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112906","article-title":"The role of inflammation in cardiovascular disease","volume":"23","author":"Henein","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0550","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.hrthm.2006.12.006","article-title":"Autonomic nerve activity and atrial fibrillation","volume":"4","author":"Chen","year":"2007","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0555","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","article-title":"Atrial remodeling and atrial fibrillation: mechanisms and implications","volume":"1","author":"Nattel","year":"2008","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"Pt 2","key":"10.1016\/j.yjmcc.2025.06.002_bb0560","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/bj3340297","article-title":"Interleukin-6-type cytokine signalling through the gp130\/Jak\/STAT pathway","volume":"334","author":"Heinrich","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0565","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.7150\/ijbs.4989","article-title":"IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6","volume":"8","author":"Rose-John","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0570","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/eji.1830230226","article-title":"The soluble interleukin-6 receptor is generated by shedding","volume":"23","author":"Mullberg","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0575","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCULATIONAHA.107.695346","article-title":"Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling","volume":"117","author":"Tsai","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0580","doi-asserted-by":"crossref","first-page":"29717","DOI":"10.1074\/jbc.M003128200","article-title":"Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes","volume":"275","author":"Sano","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0585","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1681\/ASN.2008040402","article-title":"Sympathetic activation in chronic renal failure","volume":"20","author":"Schlaich","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0590","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.5114\/aoms.2019.89452","article-title":"The role of interleukin-6 in intracellular signal transduction after chronic beta-adrenergic stimulation in mouse myocardium","volume":"15","author":"Dziemidowicz","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0595","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2215\/CJN.13121215","article-title":"Inflammation and progression of CKD: the CRIC study","volume":"11","author":"Amdur","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148189","article-title":"Interleukin-6 is a risk factor for atrial fibrillation in chronic kidney disease: findings from the CRIC study","volume":"11","author":"Amdur","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0605","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2009.503","article-title":"European uremic toxin work, plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease","volume":"77","author":"Barreto","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0610","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra1804281","article-title":"Anemia of inflammation","volume":"381","author":"Ganz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0615","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1681\/ASN.2020050595","article-title":"Ziltivekimab for treatment of anemia of inflammation in patients on hemodialysis: results from a phase 1\/2 multicenter, randomized, double-blind, placebo-controlled trial","volume":"32","author":"Pergola","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0620","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.kint.2018.02.026","article-title":"Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease","volume":"94","author":"Durlacher-Betzer","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0625","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0630","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0635","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ndt\/gfy006","article-title":"Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts","volume":"33","author":"Leifheit-Nestler","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0640","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.7150\/thno.32352","article-title":"Blocking interleukin-6 trans-signaling protects against renal fibrosis by suppressing STAT3 activation","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0645","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003396","article-title":"Signal transducer and activator of transcription 3\/MicroRNA-21 feedback loop contributes to atrial fibrillation by promoting atrial fibrosis in a rat sterile pericarditis model","volume":"9","author":"Huang","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0650","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","article-title":"The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk","volume":"48","author":"Popa","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0655","first-page":"1000","article-title":"Singh, evaluation of serum tumor necrosis factor alpha and its correlation with histology in chronic kidney disease, stable renal transplant and rejection cases","volume":"20","author":"Sonkar","year":"2009","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0660","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000340033","article-title":"Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure","volume":"36","author":"Therrien","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0665","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.2015.162","article-title":"Macrophage-derived tumor necrosis factor-alpha mediates diabetic renal injury","volume":"88","author":"Awad","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0670","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2013.08.078","article-title":"Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis","volume":"169","author":"Wu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0675","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/14017430802651803","article-title":"Activated nuclear factor-kappaB and increased tumor necrosis factor-alpha in atrial tissue of atrial fibrillation","volume":"43","author":"Qu","year":"2009","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0680","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cardiores.2007.06.003","article-title":"Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones","volume":"76","author":"Turner","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0685","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1253\/circj.CJ-12-1155","article-title":"Role of tumor necrosis factor-alpha in the pathogenesis of atrial fibrosis and development of an arrhythmogenic substrate","volume":"77","author":"Liew","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0690","doi-asserted-by":"crossref","first-page":"H1456","DOI":"10.1152\/ajpheart.00733.2004","article-title":"Atrial contractile dysfunction, fibrosis, and arrhythmias in a mouse model of cardiomyopathy secondary to cardiac-specific overexpression of tumor necrosis factor-alpha","volume":"289","author":"Saba","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0695","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00335-022-09964-x","article-title":"Mouse models of spontaneous atrial fibrillation","volume":"34","author":"Keefe","year":"2023","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0700","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ejhf.1403","article-title":"Potential role for interleukin-1 in the cardio-renal syndrome","volume":"21","author":"Buckley","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0705","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.jacc.2018.03.490","article-title":"Inhibition of interleukin-1beta by Canakinumab and cardiovascular outcomes in patients with chronic kidney disease","volume":"71","author":"Ridker","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0710","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/CIRCRESAHA.120.316710","article-title":"Atrial myocyte NLRP3\/CaMKII nexus forms a substrate for postoperative atrial fibrillation","volume":"127","author":"Heijman","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0715","first-page":"1940","article-title":"Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice","volume":"119","author":"Chelu","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0720","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1182\/blood.V75.6.1305.1305","article-title":"Interleukin-1 induces interleukin-6 production in peripheral blood monocytes","volume":"75","author":"Tosato","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110384","article-title":"Colchicine prevents atrial fibrillation promotion by inhibiting IL-1beta-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model","volume":"129","author":"Wu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0730","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1002\/jcp.27427","article-title":"Interleukin-18 and diabetic nephropathy: a review","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0735","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/art.20064","article-title":"Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis","volume":"50","author":"Dai","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0740","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.diabres.2008.11.018","article-title":"Upregulated IL-18 expression in type 2 diabetic subjects with nephropathy: TGF-beta1 enhanced IL-18 expression in human renal proximal tubular epithelial cells","volume":"83","author":"Miyauchi","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0745","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1755-5922.2010.00218.x","article-title":"Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy","volume":"30","author":"Elmarakby","year":"2012","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0750","doi-asserted-by":"crossref","first-page":"37069","DOI":"10.1074\/jbc.M103574200","article-title":"A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways","volume":"276","author":"Morel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0755","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1365-2567.2003.01747.x","article-title":"Selective regulation of intercellular adhesion molecule-1 expression by interleukin-18 and interleukin-12 on human monocytes","volume":"110","author":"Stuyt","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0760","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.18632\/aging.103149","article-title":"Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: a cross-sectional study","volume":"12","author":"Maida","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0765","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/europace\/euq321","article-title":"Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease","volume":"12","author":"Luan","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0770","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10840-022-01125-z","article-title":"MiRNA21 and IL-18 levels in left atrial blood in patients with atrial fibrillation undergoing cryoablation and their predictive value for recurrence of atrial fibrillation","volume":"64","author":"Liu","year":"2022","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0775","doi-asserted-by":"crossref","DOI":"10.20517\/jca.2022.21","article-title":"In-depth characterization of a mouse model of postoperative atrial fibrillation","volume":"2","author":"Keefe","year":"2022","journal-title":"J. Cardiovasc. Aging"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0780","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167517","article-title":"Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation","volume":"133","author":"Song","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0785","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pathol.2017.01.003","article-title":"The role of interleukin-17A in the pathogenesis of kidney diseases","volume":"49","author":"Cortvrindt","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0790","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2011.10.002","article-title":"Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients","volume":"141","author":"Chung","year":"2012","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0795","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/593170","article-title":"Correlation of interleukin-17-producing effector memory T cells and CD4+CD25+Foxp3 regulatory T cells with the phosphate levels in chronic hemodialysis patients","volume":"2014","author":"Lang","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0800","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.imlet.2019.04.002","article-title":"Analysis of interleukin-17 and interleukin-23 for estimating disease activity and predicting the response to treatment in active lupus nephritis patients","volume":"210","author":"Dedong","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0805","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0810","first-page":"246","article-title":"Increased IL-17A in atrial fibrillation correlates with neutrophil to lymphocyte ratio","volume":"11","author":"Nikoo","year":"2014","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0815","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.927221","article-title":"Immune remodeling and atrial fibrillation","volume":"13","author":"Yao","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109422","article-title":"Comparative transcriptome analysis to elucidate the therapeutic mechanism of colchicine against atrial fibrillation","volume":"119","author":"Yue","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0825","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.jacc.2010.12.030","article-title":"Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation","volume":"57","author":"von Vietinghoff","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0830","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.immuni.2008.07.018","article-title":"Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction","volume":"29","author":"Ogura","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0835","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3892\/ijmm.2015.2204","article-title":"Interleukin-17A contributes to the development of post-operative atrial fibrillation by regulating inflammation and fibrosis in rats with sterile pericarditis","volume":"36","author":"Fu","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0840","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0845","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s40200-018-0349-3","article-title":"An association between IL-10 promoter polymorphisms and diabetic nephropathy: a meta-analysis of case-control studies","volume":"17","author":"Naing","year":"2018","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0850","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1681\/ASN.2005030297","article-title":"IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease","volume":"16","author":"Mu","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0855","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.006040","article-title":"Interleukin 10 treatment ameliorates high-fat diet-induced inflammatory atrial remodeling and fibrillation","volume":"11","author":"Kondo","year":"2018","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0860","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hrthm.2015.07.001","article-title":"Splenectomy exacerbates atrial inflammatory fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats: possible role of spleen-derived interleukin-10","volume":"13","author":"Kondo","year":"2016","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0865","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2022.03.379","article-title":"Inflammasome Signaling in atrial fibrillation: JACC state-of-the-art review","volume":"79","author":"Ajoolabady","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0870","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41569-022-00759-w","article-title":"Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology","volume":"20","author":"Dobrev","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0875","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0880","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41419-020-02912-0","article-title":"ELABELA attenuates deoxycorticosterone acetate\/salt-induced hypertension and renal injury by inhibition of NADPH oxidase\/ROS\/NLRP3 inflammasome pathway","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0885","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1080\/15548627.2020.1848971","article-title":"Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy","volume":"17","author":"Lin","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0890","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1002\/jcb.27714","article-title":"Artemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF-kappaB\/NLRP3 pathway in rats with 5\/6 subtotal nephrectomy","volume":"120","author":"Wen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0895","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3389\/fphys.2018.01726","article-title":"Chronic kidney disease increases atrial fibrillation inducibility: involvement of inflammation, atrial fibrosis, and connexins","volume":"9","author":"Qiu","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0900","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-981-13-9367-9_7","article-title":"AIM2 inflammasome assembly and signaling","volume":"1172","author":"Wang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0905","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/eji.201848070","article-title":"Role of AIM2 inflammasome in inflammatory diseases, cancer and infection","volume":"49","author":"Sharma","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0910","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1681\/ASN.2017080863","article-title":"Macrophage uptake of necrotic cell DNA activates the AIM2 inflammasome to regulate a proinflammatory phenotype in CKD","volume":"29","author":"Komada","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0915","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.582482","article-title":"AIM2 stimulation impairs Reendothelialization and promotes the development of atherosclerosis in mice","volume":"7","author":"Lusebrink","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0920","doi-asserted-by":"crossref","first-page":"6774416","DOI":"10.1155\/2022\/6774416","article-title":"The Association of Serum AIM2 level with the prediction and short-term prognosis of coronary artery disease","volume":"2022","author":"Zhang","year":"2022","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0925","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.4161\/hv.28333","article-title":"Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis","volume":"10","author":"Chai","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0930","first-page":"2639","article-title":"AIM2-driven inflammasome activation in heart failure","volume":"117","author":"Onodi","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/cells13020108","article-title":"A high-protein diet promotes atrial arrhythmogenesis via absent-in-melanoma 2 inflammasome","volume":"13","author":"Song","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0940","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.mehy.2007.04.046","article-title":"The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation","volume":"70","author":"Li","year":"2008","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0945","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.RES.0000129579.59664.9d","article-title":"Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1","volume":"94","author":"Verheule","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0950","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.RES.86.5.571","article-title":"Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart","volume":"86","author":"Nakajima","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0955","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fcell.2020.00123","article-title":"Diverse role of TGF-beta in kidney disease","volume":"8","author":"Gu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0960","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149513","article-title":"Serum TGF-beta1 as a biomarker for type 2 diabetic nephropathy: a meta-analysis of randomized controlled trials","volume":"11","author":"Mou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0965","doi-asserted-by":"crossref","first-page":"F118","DOI":"10.1152\/ajprenal.00021.2008","article-title":"Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease","volume":"295","author":"Huang","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0970","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1681\/ASN.2015111230","article-title":"Anti-TGF-beta1 antibody therapy in patients with diabetic nephropathy","volume":"28","author":"Voelker","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0975","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ki.2011.33","article-title":"A phase 1, single-dose study of fresolimumab, an anti-TGF-beta antibody, in treatment-resistant primary focal segmental glomerulosclerosis","volume":"79","author":"Trachtman","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0980","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ekir.2017.03.011","article-title":"A phase 2, double-blind, placebo-controlled, randomized study of fresolimumab in patients with steroid-resistant primary focal segmental glomerulosclerosis","volume":"2","author":"Vincenti","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0985","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/1090820X13477860","article-title":"Exploratory, randomized, controlled, phase 2 study to evaluate the safety and efficacy of adjuvant fibrin sealant VH S\/D 4 S-Apr (ARTISS) in patients undergoing rhytidectomy","volume":"33","author":"Hester","year":"2013","journal-title":"Aesthet. Surg. J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0990","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1111\/jcmm.14454","article-title":"Petchiether a attenuates obstructive nephropathy by suppressing TGF-beta\/Smad3 and NF-kappaB signalling","volume":"23","author":"You","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb0995","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008083","article-title":"Elevated circulating fibrocytes is a marker of left atrial fibrosis and recurrence of persistent atrial fibrillation","volume":"7","author":"Liu","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1000","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.kint.2021.10.025","article-title":"A systematic review and meta-analysis of murine models of uremic cardiomyopathy","volume":"101","author":"Soppert","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1005","first-page":"72","article-title":"Kidney disease models: tools to identify mechanisms and potential therapeutic targets","volume":"39","author":"Bao","year":"2018","journal-title":"Zool. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1010","first-page":"448","article-title":"Chronic Kidney disease and atrial fibrillation: a contemporary overview","volume":"5","author":"Kulkarni","year":"2012","journal-title":"J. Atr. Fibrillat."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2215\/CJN.00920805","article-title":"Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation","volume":"1","author":"Lentine","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1020","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/ajt.12197","article-title":"Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation","volume":"13","author":"Lenihan","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1025","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ndt\/15.6.765","article-title":"Atrial fibrillation in dialysis patients","volume":"15","author":"Zebe","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000119694","article-title":"Paranoid psychosis and myoclonus: flecainide toxicity in renal failure","volume":"111","author":"Ting","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.hrthm.2010.10.047","article-title":"Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up","volume":"8","author":"Naruse","year":"2011","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1040","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1540-8167.2012.02422.x","article-title":"Outcomes of ablation of paroxysmal atrial fibrillation in patients on chronic hemodialysis","volume":"23","author":"Sairaku","year":"2012","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5603\/CJ.2013.0104","article-title":"Rate versus rhythm control and outcomes in patients with atrial fibrillation and chronic kidney disease: data from the GUSTO-III trial","volume":"20","author":"Williams","year":"2013","journal-title":"Cardiol. J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1050","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/euhj.1998.1050","article-title":"Atrial fibrillation: current knowledge and recommendations for management","volume":"19","author":"Levy","year":"1998","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.2014.195","article-title":"Morbidity and treatment in patients with atrial fibrillation and chronic kidney disease","volume":"87","author":"Reinecke","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1060","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1681\/ASN.2009030319","article-title":"Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation","volume":"20","author":"Chan","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/0886022X.2021.1901739","article-title":"Estrogen and estrogen receptors in kidney diseases","volume":"43","author":"Ma","year":"2021","journal-title":"Ren. Fail."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1070","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.semnephrol.2021.03.007","article-title":"Amenorrhea and estrogen disorders in kidney disease","volume":"41","author":"Rojas","year":"2021","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1075","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1136\/heartjnl-2016-311002","article-title":"Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation","volume":"103","author":"Wong","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1080","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Women\u2019s Health Initiative, Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1085","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1177\/1535370217718808","article-title":"Protective regulation of the ACE2\/ACE gene expression by estrogen in human atrial tissue from elderly men","volume":"242","author":"Bukowska","year":"2017","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0008-6363(01)00526-0","article-title":"Estrogenic hormone action in the heart: regulatory network and function","volume":"53","author":"Babiker","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1095","article-title":"Male and female atria exhibit distinct acute electrophysiological responses to sex steroids","volume":"9","author":"Wells","year":"2024","journal-title":"J. Mol. Cell Cardiol. Plus"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/bja\/ael224","article-title":"Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery","volume":"97","author":"Ristikankare","year":"2006","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/01.CCM.0000295305.22281.1D","article-title":"N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial","volume":"36","author":"Sisillo","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1110","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2017.06.011","article-title":"Protective effect of N-acetylcysteine on progression to end-stage renal disease: necessity for prospective clinical trial","volume":"44","author":"Liao","year":"2017","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1115","first-page":"2472","article-title":"N-acetylcysteine for chronic kidney disease: a systematic review and meta-analysis","volume":"13","author":"Ye","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1120","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.kint.2022.06.022","article-title":"A randomized controlled pilot trial of anakinra for hemodialysis inflammation","volume":"102","author":"Dember","year":"2022","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13539-013-0115-9","article-title":"Anti-inflammatory and anti-oxidative nutrition in Hypoalbuminemic dialysis patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial","volume":"4","author":"Rattanasompattikul","year":"2013","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10840-016-0186-6","article-title":"The addition of renal sympathetic denervation to pulmonary vein isolation reduces recurrence of paroxysmal atrial fibrillation in chronic kidney disease patients","volume":"48","author":"Kiuchi","year":"2017","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jama.2019.21187","article-title":"Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial","volume":"323","author":"Steinberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1140","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1161\/CIRCRESAHA.121.320104","article-title":"Renal denervation prevents atrial Arrhythmogenic substrate development in CKD","volume":"130","author":"Hohl","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1145","article-title":"Renal denervation suppresses atrial fibrillation in a model of renal impairment","volume":"10","author":"Liang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1150","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/rth2.12250","article-title":"Atrial fibrillation in patients with end-stage renal disease on hemodialysis: magnitude of the problem and new approach to oral anticoagulation","volume":"3","author":"Konigsbrugge","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1155","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.122.011466","article-title":"Chronic kidney disease induces proarrhythmic remodeling","volume":"16","author":"King","year":"2023","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065373","article-title":"Pro-arrhythmic potential of accumulated uremic toxins is mediated via vulnerability of action potential repolarization","volume":"24","author":"van Ham","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.yjmcc.2014.09.021","article-title":"Development of an experimentally useful model of acute myocardial infarction: 2\/3 nephrectomized triple nitric oxide synthases-deficient mouse","volume":"77","author":"Uchida","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1170","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2353\/ajpath.2010.090528","article-title":"Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes","volume":"176","author":"Gaikwad","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042266","article-title":"Unilateral acute renal ischemia-reperfusion injury induces cardiac dysfunction through intracellular calcium mishandling","volume":"23","author":"Junho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1180","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/ndt\/gfx304","article-title":"Pre-clinical model of severe glutathione peroxidase-3 deficiency and chronic kidney disease results in coronary artery thrombosis and depressed left ventricular function","volume":"33","author":"Pang","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1185","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/ndt\/gfs569","article-title":"Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice","volume":"28","author":"Santana","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1190","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41598-020-80063-0","article-title":"Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1195","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2013.207","article-title":"NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy","volume":"84","author":"Knauf","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1200","doi-asserted-by":"crossref","first-page":"F785","DOI":"10.1152\/ajprenal.00488.2015","article-title":"Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL\/6 mice","volume":"310","author":"Mulay","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","article-title":"A review of clinical characteristics and genetic backgrounds in Alport syndrome","volume":"23","author":"Nozu","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.yjmcc.2025.06.002_bb1210","doi-asserted-by":"crossref","first-page":"F343","DOI":"10.1152\/ajprenal.00240.2018","article-title":"MCP-1 promotes detrimental cardiac physiology, pulmonary edema, and death in the cpk model of polycystic kidney disease","volume":"317","author":"Salah","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282825000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282825000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:57:00Z","timestamp":1778878620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282825000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":242,"alternative-id":["S0022282825000926"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2025.06.002","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms underlying atrial fibrillation in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2025.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}